| Prev Close: | 21.71 |
|---|---|
| Open: | 21.48 |
| Bid: | 18.47 x 500 |
| Ask: | 36.08 x 100 |
| 1y Target Est: | 22.29 |
| Beta: | 1.38 |
| Next Earnings Date: | 22-Jul-13 |
| Day's Range: | 21.32 - 21.77 |
|---|---|
| 52wk Range: | 16.19 - 23.05 |
| Volume: | 121,037 |
| Avg Vol (3m): | 172,915 |
| Market Cap: | 898.18M |
| P/E (ttm): | 25.19 |
| EPS (ttm): | 0.86 |
| Div & Yield: | 0.76 (3.50%) |
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- VIVO January 2014 Options Begin Tradingat Forbes(Mon, May 20)
- MERIDIAN BIOSCIENCE INC FinancialsEDGAR Online Financials(Fri, May 17)
- MERIDIAN BIOSCIENCE INC Files SEC form 10-Q, Quarterly ReportEDGAR Online(Fri, May 10)
- 9 Top Healthcare Dogs Hunt 3.5% To 51.9% Gains In Aprilat Seeking Alpha(Mon, May 6)
- This ETF Holds Stocks Insiders Want to Ownat Forbes(Mon, May 6)
- Friday 5/3 Insider Buying Report: HTCH, VIVOat Forbes(Fri, May 3)
- Meridian Bioscience About To Put More Money In Your Pocketat Forbes(Tue, Apr 30)
- Meridian Bioscience Named Top Dividend Stock With Insider Buying and 3.88% Yieldat Forbes(Mon, Apr 29)
- 1 Winner and 4 Losers from This Week’s Earnings Stormat Wall St. Cheat Sheet(Sun, Apr 28)
- Top Ranked Dividend Stock VIVO Enters Oversold Territoryat TheStreet(Fri, Apr 26)
- Notable Two Hundred Day Moving Average Cross - VIVOat Forbes(Fri, Apr 26)
- MERIDIAN BIOSCIENCE INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and EEDGAR Online(Fri, Apr 26)
- Meridian Bioscience Earnings: Here’s Why Investors Don’t Like These Resultsat Wall St. Cheat Sheet(Thu, Apr 25)
- Meridian Bioscience Reports Second Quarter and Six Months Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2013 GuidanceBusiness Wire(Thu, Apr 25)
- Q2 2013 Meridian Bioscience, Inc. Earnings Release - Before Market OpenCCBN(Thu, Apr 25)
Press Releases
- Meridian Bioscience Reports Second Quarter and Six Months Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2013 GuidanceBusiness Wire(Thu, Apr 25)
- Meridian Bioscience Recognized by Forbes as One of America’s 100 Most Trustworthy CompaniesBusiness Wire(Thu, Mar 28)
- Meridian Bioscience Announces illumigene® Group A Streptococcus and illumigene® Group B Streptococcus Tests Categorized “Moderate Complexity” by FDABusiness Wire(Mon, Mar 18)
Reports
- VIVO: Due Diligence Review: Forensic Earnings and ValuationNew Constructs, LLC(May 23)
- Trading Report for (VIVO). A detailed report, including free correlated market...Stock Traders Daily(May 23)
- ValuEngine Detailed Valuation Report for VIVOValuEngine, Inc.(May 23)